期刊文献+

骨密度和25羟维生素D在骨质疏松性髋部骨折的作用 被引量:20

The effect of bone mineral density and 25OHD on the osteoporotic hip fracture
下载PDF
导出
摘要 目的在股骨颈骨密度达到骨质疏松阈值的情况下,比较髋部骨折与无髋部骨折患者的年龄、骨密度和25羟维生素D,了解这些因素对髋部骨折的影响。方法对137例骨密度达到骨质疏松阈值的绝经后女性患者进行研究,无髋部骨折组62例,髋部骨折组75例,检测股骨颈骨密度和血清25羟维生素D,比较二组年龄、股骨颈骨密度和25羟维生素D水平。结果无髋部骨折组:年龄:(67.92±8.52)岁,股骨颈骨密度:(0.5064±0.0706)g/cm2,T值:-3.10±0.60,25OHD:(24.90±8.98)ng/ml。髋部骨折组:年龄:(78.49±8.52)岁,股骨颈骨密度:(0.4506±0.0983)g/cm2,T值:-3.51±1.18,25OHD:(14.89±8.94)ng/ml。结论在股骨颈骨密度达到骨质疏松阈值的情况下,髋部骨折患者具有更高年龄,更低骨密度和25羟维生素D。 Objective To compareage,bonemineral density,and 25 OHD between theosteoporotic patients with and without hip fractures for understanding influenceof thesefactors in thehip fracture. Methods Therewere137 postmenopausal women with BMD under- 2. 5 SD in thefemoral neck in our series,including 62 patients without hip fractureand 75 patients with hip fracture.BMD measurement of femoral neck and serum 25 OHD wereexamined. Age,BMD,and 25 OHD werecompared between thepatients with and without hip fractures. Results Theage,BMD of thefemoral neck,T score,and 25 OHD were67. 92 ± 8. 52 yrs,0. 5064 ± 0. 0706 g / cm2,- 3. 10 ± 0. 60,and 24. 90 ± 8. 98 ng /ml,respectively,in theosteoporotic patients without hip fracture. They were78. 49 ± 8. 52 yrs,0. 4506 ± 0. 0983 g / cm2,- 3. 51 ± 1. 18,and 14. 89 ± 8. 94 ng /ml,respectively,in theosteoporotic patients with hip fracture. Conclusion Under thecondition of T≤- 2. 5 SD of femoral neck BMD,thepatients with hip fractureareolder,lower in femoral neck BMD and 25 OHD than thepatients without hip fracture.
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2015年第12期1457-1459,共3页 Chinese Journal of Osteoporosis
基金 福建省医药卫生科技创新项目(2015-CXB-18) 泉州市科技项目(2014Z44)
关键词 骨质疏松 髋部骨折 骨密度 25羟维生素D Osteoporosis Hip fracture Bone mineral density 25OHD
  • 相关文献

参考文献15

二级参考文献55

  • 1李毅中,陈献南,李炎川.高龄老人股骨颈骨质疏松性骨折的治疗[J].中国骨质疏松杂志,2005,11(3):342-343. 被引量:21
  • 2何威,杨力,蔡德鸿.骨形成与吸收过程中的代谢生化标记物[J].中国临床康复,2005,9(42):118-120. 被引量:15
  • 3梁敏,廖二元.体重、体重指数对健康绝经后妇女骨密度的影响[J].中国老年学杂志,2006,26(1):28-30. 被引量:41
  • 4中国健康促进基金会骨质疏松防治中国白皮书编委会.骨质疏松症中国白皮书.中华健康管理学杂志,2009,3(3):148-156.
  • 5NIH Consensus Development Panel on Osteoporosis Prevention. Diagnosis and Therapy. JAMA ,2001,285:785-795.
  • 6Kusumi T, Kusumi A. Osteocalcin/bone Gla protein (BGP). J Nippon Rinsho ,2004, 62 ( Suppl2 ) : 126-140.
  • 7Ross PD, Kress BC, Parson RE, et al. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporosis Int,2000,11:76-82.
  • 8Garnero P, Sornay-Rendu E, Claustrar B, et al. Biochemical Markers of bone turnover, endogenous hormones and the risk of fracture in postmenpausal women: the OFELY study. J Bone Miner Res, 2000, 15:1526-1536.
  • 9Kanis JA, Melton LJ 3rd,Chfistiansen C, et al. The diagnosis of osteoporosis. J Bone Miner Res, 1994, 9(8) :1137-1141.
  • 10Sosa M, Lainez P, Arbelo A, et al. The effect of 1, 25-di- hydroxyvitamin D on the bone mineral metabolism of elderly women with hip fracture. Rheumatology (Oxford) , 2009, 39 ( 11 ) : 1263-1268.

共引文献121

同被引文献186

引证文献20

二级引证文献206

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部